Phoenix Molecular Imaging
Call Us: 480.881.5621
My experience with the center was outstanding and I would not hesitate to recommend them. Kind, professional, caring and willing to take the time needed to insure all your questions are answered.
- Brian, Albuquerque NM
Thank you for spending the time with my wife and me. That was first time that the Dr. responsible for reading my Scan spent the time explaining exactly what the scan represents and the significant changes in such great detail.
- William, San Diego CA
As I am sitting here completing a treatment plan on Mr. P, I want to thank you once again for your excellent care and for the ability that you have granted to me to review the C11 images from your center online. What a difference in terms of treatment planning and targeting! Good stuff all around. Makes me wonder how I ever treated anybody in the past…
- Dr. Carl Rossi MD, Director Scripps Proton Therapy Center
I am very grateful for all the time you gave to me to explain what was going to happen in the process of the scans (along with a lot of other relevant information). I particularly appreciate the time you devoted to explaining to me what the scans showed and observing the condition of various parts of my body. It is the most in-depth examination/explanation I’ve ever had. I also appreciated our discussion of many things related to prostate cancer, treatments and side effects. Thank you!! Thank you!!
And please express my thanks to your staff who were efficient, but at the same time very gracious, making my time with them most pleasant.
- Dwight, Evergreen CO
We are a staff of physicians and researchers with a specialized imaging facility performing PET/CT imaging and multiple research imaging studies.
We are a specialized imaging facility with an on-site cyclotron and radiopharmacy production facility – the only private facility of its kind in the U.S. The first and only facility in the Western U.S. approved to produce and use C11-Acetate for the evaluation of prostate cancer under multiple clinical trials.
The physicians at Phoenix Molecular are conducting studies to determine how well C11-Acetate PET/CT scans can improve their ability to detect residual or recurrent prostate cancer and other cancers.
Today cancer patients have more treatment options than ever before. Through advanced imaging, such as C11-Acetate PET/CT, we now can know the true limit or extent of prostate cancer. With this information, better treatment decisions can be made.
View our recent publication in the American Journal of Nuclear Medicine and Molecular Imaging - Am J Nucl Med Mol Imaging 2017;7(1):1-11